I recently shared a BMJ report that outlined the approval of Esketamine in Europe: Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products … Continue reading Esketamine: Regulators and a confusing narrative
The BMJ has published this News report, the full article can be accessed here.
As part of the 2019 Summer Meeting the British Association for Psychopharmacology has organised a ‘Trainees’ Workshop’ chaired by Professor Jeremy Hall and with the following five speakers: I have … Continue reading Trainees’ Workshop
The January 2019 edition of the British Journal of Psychiatry has, as its theme: Treatment-Resistant Mood Disorders. In the Journal a “consensus definition” of “treatment resistance” was provided by a … Continue reading “A wrong un’ when you see it”
The current edition of the British Journal of Psychiatry, May 2018, contains academic papers on depressive disorders. In this post I will share some of the declarations of interest linked … Continue reading The British Journal of Psychiatry: are competing interests of authors sufficiently transparent?